Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients
Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients
Recruiting · NCT07709013 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 2 | 2026-07-16 | NCT07709013 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Indian Council of Medical Research | 29 |
| Tata Memorial Centre | 50 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Advanced Centre for Treatment, Research and Education in Cancer | Navi Mumbai | India | 5 |
| Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Tata Memorial Centre | Navi Mumbai | India | 1 |